Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States. Each year, approximately 250,000 men in the U.S. receive a prostate cancer ...
A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
Driven by the rising global cancer burden, aging populations, and rapid adoption of AI-powered digital pathology, the ...
Benefits include better discrimination between risk levels. (HealthDay News) — Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current ...
Individual patient data (IPD) analysis of early PSA nadir in ARASENS, LATITUDE, and TITAN: Training and validation of a novel model. Assessing genomic instability (GI) by shallow whole-genome ...
If you’ve recently been diagnosed with prostate cancer, or if you’ve had a prostate biopsy to test for prostate cancer, you might have seen the term “Gleason score” or “Gleason grade” on the pathology ...
Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback